Published in Ann Med on December 12, 2011
Increasing prevalence of nonalcoholic fatty liver disease among United States adolescents, 1988-1994 to 2007-2010. J Pediatr (2012) 1.72
Body fat content and distribution and urinary risk factors for nephrolithiasis. Clin J Am Soc Nephrol (2013) 1.51
Body mass index in dementia. Eur J Clin Nutr (2014) 0.87
Rationale and design of South Asian Birth Cohort (START): a Canada-India collaborative study. BMC Public Health (2013) 0.83
Greater Skeletal Muscle Fat Infiltration Is Associated With Higher All-Cause and Cardiovascular Mortality in Older Men. J Gerontol A Biol Sci Med Sci (2015) 0.83
The relative contributions of the abdominal visceral and subcutaneous fat depots to cardiometabolic risk in youth. Clin Obes (2014) 0.80
Metabolically healthy and unhealthy obesity: differential effects on myocardial function according to metabolic syndrome, rather than obesity. Int J Obes (Lond) (2015) 0.79
Long-term risperidone treatment induces visceral adiposity associated with hepatic steatosis in mice: a magnetic resonance approach. Schizophr Res Treatment (2014) 0.77
Isocaloric high-fat feeding directs hepatic metabolism to handling of nutrient imbalance promoting liver fat deposition. Int J Obes (Lond) (2016) 0.77
Mast cell deficiency exacerbates inflammatory bowel symptoms in interleukin-10-deficient mice. World J Gastroenterol (2014) 0.77
Muscle Attenuation Is Associated With Newly Developed Hypertension in Men of African Ancestry. Hypertension (2017) 0.75
Heart disease and stroke statistics--2015 update: a report from the American Heart Association. Circulation (2014) 22.74
Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation (2015) 10.14
Sugar-sweetened beverages and risk of metabolic syndrome and type 2 diabetes: a meta-analysis. Diabetes Care (2010) 8.52
Sugar-sweetened beverages, obesity, type 2 diabetes mellitus, and cardiovascular disease risk. Circulation (2010) 6.86
Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol (2008) 5.19
Pathophysiology of human visceral obesity: an update. Physiol Rev (2013) 4.41
Short sleep duration is associated with reduced leptin levels and increased adiposity: Results from the Quebec family study. Obesity (Silver Spring) (2007) 3.23
International Day for the Evaluation of Abdominal Obesity (IDEA): a study of waist circumference, cardiovascular disease, and diabetes mellitus in 168,000 primary care patients in 63 countries. Circulation (2007) 3.01
Assessing adiposity: a scientific statement from the American Heart Association. Circulation (2011) 3.00
Transradial approach for coronary angiography and interventions: results of the first international transradial practice survey. JACC Cardiovasc Interv (2010) 2.95
Executive Summary: Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation (2016) 2.87
Low-density lipoprotein subfractions and the long-term risk of ischemic heart disease in men: 13-year follow-up data from the Québec Cardiovascular Study. Arterioscler Thromb Vasc Biol (2004) 2.50
The association between sleep duration and weight gain in adults: a 6-year prospective study from the Quebec Family Study. Sleep (2008) 2.30
A randomized study comparing same-day home discharge and abciximab bolus only to overnight hospitalization and abciximab bolus and infusion after transradial coronary stent implantation. Circulation (2006) 2.17
Implantation of CD133+ stem cells in patients undergoing coronary bypass surgery: IMPACT-CABG pilot trial. Can J Cardiol (2012) 2.02
Cerebral embolism following transcatheter aortic valve implantation: comparison of transfemoral and transapical approaches. J Am Coll Cardiol (2011) 2.02
High-density lipoprotein particle size and concentration and coronary risk. Ann Intern Med (2009) 2.02
Complementary prognostic values of stress myocardial perfusion and late gadolinium enhancement imaging by cardiac magnetic resonance in patients with known or suspected coronary artery disease. Circulation (2009) 2.01
Visceral obesity: the link among inflammation, hypertension, and cardiovascular disease. Hypertension (2009) 2.00
Efficacy and safety of rimonabant for improvement of multiple cardiometabolic risk factors in overweight/obese patients: pooled 1-year data from the Rimonabant in Obesity (RIO) program. Diabetes Care (2008) 2.00
Insulin resistance syndrome, body mass index and the risk of ischemic heart disease. CMAJ (2005) 1.86
Impact of waist circumference on the relationship between blood pressure and insulin: the Quebec Health Survey. Hypertension (2005) 1.83
Nonrandomized comparison of coronary artery bypass surgery and percutaneous coronary intervention for the treatment of unprotected left main coronary artery disease in octogenarians. Circulation (2008) 1.69
Hypertriglyceridemic waist: a useful screening phenotype in preventive cardiology? Can J Cardiol (2007) 1.64
Aging per se does not influence glucose homeostasis: in vivo and in vitro evidence. Diabetes Care (2003) 1.62
Predictive factors, efficacy, and safety of balloon post-dilation after transcatheter aortic valve implantation with a balloon-expandable valve. JACC Cardiovasc Interv (2012) 1.60
Visceral obesity and the heart. Int J Biochem Cell Biol (2007) 1.58
Middle-aged men with increased waist circumference and elevated C-reactive protein level are at higher risk for postoperative atrial fibrillation following coronary artery bypass grafting surgery. Eur Heart J (2009) 1.57
Metabolic syndrome is associated with faster degeneration of bioprosthetic valves. Circulation (2006) 1.55
The effect of topiramate on energy balance in obese men: a 6-month double-blind randomized placebo-controlled study with a 6-month open-label extension. Eur J Clin Pharmacol (2007) 1.54
Predictive factors and long-term clinical consequences of persistent left bundle branch block following transcatheter aortic valve implantation with a balloon-expandable valve. J Am Coll Cardiol (2012) 1.52
Retrograde recanalization of chronic total occlusions from the transradial approach; early Canadian experience. Catheter Cardiovasc Interv (2011) 1.51
Sex differences in inflammatory markers: what is the contribution of visceral adiposity? Am J Clin Nutr (2009) 1.51
Concordance/discordance between plasma apolipoprotein B levels and the cholesterol indexes of atherosclerotic risk. Am J Cardiol (2003) 1.50
Sleep duration as a risk factor for the development of type 2 diabetes or impaired glucose tolerance: analyses of the Quebec Family Study. Sleep Med (2009) 1.49
Evidence for impaired lipolysis in abdominally obese men: postprandial study of apolipoprotein B-48- and B-100-containing lipoproteins. Am J Clin Nutr (2002) 1.49
Development of an atherogenic metabolic risk factor profile associated with the use of atypical antipsychotics. J Clin Psychiatry (2004) 1.49
Diabetes: Looking back at Look AHEAD--giving lifestyle a chance. Nat Rev Cardiol (2013) 1.49
Comparison of medical treatment and coronary revascularization in patients with moderate coronary lesions and borderline fractional flow reserve measurements. Catheter Cardiovasc Interv (2008) 1.48
The hypertriglyceridemic-waist phenotype and the risk of coronary artery disease: results from the EPIC-Norfolk prospective population study. CMAJ (2010) 1.45
Early and late outcomes in patients excluded from same-day home discharge after transradial stenting and maximal antiplatelet therapy. Catheter Cardiovasc Interv (2008) 1.45
Clinical outcomes after multilesion percutaneous coronary intervention: comparison between exclusive and selective use of drug-eluting stents. J Invasive Cardiol (2008) 1.45
Validation and characterization of transcatheter aortic valve effective orifice area measured by Doppler echocardiography. JACC Cardiovasc Imaging (2011) 1.44
Waist circumference, visceral obesity, and cardiovascular risk. J Cardiopulm Rehabil (2003) 1.43
Drug-eluting or bare metal stents for the treatment of saphenous vein graft disease: a Bayesian meta-analysis. Circ Cardiovasc Interv (2010) 1.43
Eating behaviors and indexes of body composition in men and women from the Québec family study. Obes Res (2003) 1.41
Importance of diffuse atherosclerosis in the functional evaluation of coronary stenosis in the proximal-mid segment of a coronary artery by myocardial fractional flow reserve measurements. Am J Cardiol (2011) 1.41
Elevated proportion of small, dense low-density lipoprotein particles and lower adiponectin blood levels predict early structural valve degeneration of bioprostheses. Cardiology (2012) 1.40
Calcium intake, body composition, and lipoprotein-lipid concentrations in adults. Am J Clin Nutr (2003) 1.40
Effects of aspiration thrombectomy on necrosis size and ejection fraction after transradial percutaneous coronary intervention in acute ST-elevation myocardial infarction. Catheter Cardiovasc Interv (2011) 1.39
Visceral obesity and plasma glucose-insulin homeostasis: contributions of interleukin-6 and tumor necrosis factor-alpha in men. J Clin Endocrinol Metab (2008) 1.39
Exercise-induced hypertension in men with metabolic syndrome: anthropometric, metabolic, and hemodynamic features. Metab Syndr Relat Disord (2012) 1.39
Long term efficacy of abciximab bolus-only compared to abciximab bolus and infusion after transradial coronary stenting. Catheter Cardiovasc Interv (2009) 1.38
Adiponectinemia in visceral obesity: impact on glucose tolerance and plasma lipoprotein and lipid levels in men. J Clin Endocrinol Metab (2004) 1.36
Inflammatory biomarkers, physical activity, waist circumference, and risk of future coronary heart disease in healthy men and women. Eur Heart J (2009) 1.31
What is a normal glucose value? Differences in indexes of plasma glucose homeostasis in subjects with normal fasting glucose. Diabetes Care (2004) 1.29
Visceral adipose tissue accumulation, cardiorespiratory fitness, and features of the metabolic syndrome. Arch Intern Med (2007) 1.26
Obesity and metabolic syndrome are independent risk factors for atrial fibrillation after coronary artery bypass graft surgery. Circulation (2007) 1.26
Postprandial variations of plasma inflammatory markers in abdominally obese men. Obesity (Silver Spring) (2006) 1.25
Cardiometabolic risk in Canada: a detailed analysis and position paper by the cardiometabolic risk working group. Can J Cardiol (2011) 1.24
Relation of the "hypertriglyceridemic waist" phenotype to earlier manifestations of coronary artery disease in patients with glucose intolerance and type 2 diabetes mellitus. Am J Cardiol (2006) 1.23
Disease prevention--should we target obesity or sedentary lifestyle? Nat Rev Cardiol (2010) 1.22
HDL particle size and the risk of coronary heart disease in apparently healthy men and women: the EPIC-Norfolk prospective population study. Atherosclerosis (2009) 1.21
Visceral adipose tissue indicates the severity of cardiometabolic risk in patients with and without type 2 diabetes: results from the INSPIRE ME IAA study. J Clin Endocrinol Metab (2012) 1.21
Risk factors for adult overweight and obesity in the Quebec Family Study: have we been barking up the wrong tree? Obesity (Silver Spring) (2009) 1.18
5' flanking variants of resistin are associated with obesity. Diabetes (2002) 1.16
Modifications in food-group consumption are related to long-term body-weight changes. Am J Clin Nutr (2004) 1.16
The impact of integration of a multidetector computed tomography annulus area sizing algorithm on outcomes of transcatheter aortic valve replacement: a prospective, multicenter, controlled trial. J Am Coll Cardiol (2013) 1.15
Contribution of abdominal obesity and hypertriglyceridemia to impaired fasting glucose and coronary artery disease. Am J Cardiol (2002) 1.15
Visceral and not subcutaneous abdominal adiposity reduction drives the benefits of a 1-year lifestyle modification program. Obesity (Silver Spring) (2012) 1.14
The association between short sleep duration and weight gain is dependent on disinhibited eating behavior in adults. Sleep (2011) 1.14
Effect of exercise training on cardiometabolic risk markers among sedentary, but metabolically healthy overweight or obese post-menopausal women with elevated blood pressure. Atherosclerosis (2009) 1.13
Metabolic syndrome: the danger signal in atherosclerosis. Vasc Health Risk Manag (2006) 1.13
CB1 antagonists for obesity--what lessons have we learned from rimonabant? Nat Rev Endocrinol (2009) 1.12
Age-related differences in inflammatory markers in men: contribution of visceral adiposity. Metabolism (2009) 1.11
Prevalence of 'hypertriglyceridemic waist' in men who participated in the Quebec Health Survey: association with atherogenic and diabetogenic metabolic risk factors. Can J Cardiol (2002) 1.11
Hypertriglyceridemic waist: a simple clinical phenotype associated with coronary artery disease in women. Metabolism (2011) 1.10
Inflammatory markers and long-term risk of ischemic heart disease in men A 13-year follow-up of the Quebec Cardiovascular Study. Atherosclerosis (2005) 1.09
Incidence, predictive factors, and prognostic value of myocardial injury following uncomplicated transcatheter aortic valve implantation. J Am Coll Cardiol (2011) 1.06
Association between plasma LDL particle size, valvular accumulation of oxidized LDL, and inflammation in patients with aortic stenosis. Arterioscler Thromb Vasc Biol (2007) 1.06
Cardiovascular magnetic resonance evaluation of aortic stenosis severity using single plane measurement of effective orifice area. J Cardiovasc Magn Reson (2012) 1.05
Contribution of age and declining androgen levels to features of the metabolic syndrome in men. Metabolism (2005) 1.04
Effects of diffusion coefficients and struts apposition using numerical simulations for drug eluting coronary stents. J Biomech Eng (2007) 1.04
Cholesterol levels in small LDL particles predict the risk of coronary heart disease in the EPIC-Norfolk prospective population study. Eur Heart J (2007) 1.04
Sex differences in postprandial plasma tumor necrosis factor-alpha, interleukin-6, and C-reactive protein concentrations. Metabolism (2009) 1.04
Congenital absence of the pericardium presenting as acute myocardial necrosis. Can J Cardiol (2007) 1.03
Metabolic syndrome negatively influences disease progression and prognosis in aortic stenosis. J Am Coll Cardiol (2006) 1.03
Metabolic syndrome increases operative mortality in patients undergoing coronary artery bypass grafting surgery. J Am Coll Cardiol (2007) 1.03
Predictive factors, management, and clinical outcomes of coronary obstruction following transcatheter aortic valve implantation: insights from a large multicenter registry. J Am Coll Cardiol (2013) 1.02
Moderate alcohol consumption is more cardioprotective in men with the metabolic syndrome. J Nutr (2006) 1.02
Greater than predicted decrease in energy expenditure during exercise after body weight loss in obese men. Clin Sci (Lond) (2003) 1.02
Metabolic syndrome is associated with more pronounced impairment of left ventricle geometry and function in patients with calcific aortic stenosis: a substudy of the ASTRONOMER (Aortic Stenosis Progression Observation Measuring Effects of Rosuvastatin). J Am Coll Cardiol (2010) 1.01
Comparison between cardiovascular magnetic resonance and transthoracic Doppler echocardiography for the estimation of effective orifice area in aortic stenosis. J Cardiovasc Magn Reson (2011) 1.01
Characterization of microvascular dysfunction after acute myocardial infarction by cardiovascular magnetic resonance first-pass perfusion and late gadolinium enhancement imaging. J Cardiovasc Magn Reson (2006) 1.01